Cited by 359Inflammatory mediators and NSAID effectsColorectal Cancer Screening and DetectionColorectal Cancer Treatments and Studies

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs

García Rodríguez, Luis A., Huerta-Alvarez, Consuelo·2001·Epidemiology

DOI 10.1097/00001648-200101000-00015

Open this paper in CoChat — free account

Abstract

Use of nonsteroidal antiinflammatory drugs (NSAIDs) has been associated with a reduced risk of colorectal cancer, but limited information is available on the effect of individual nonaspirin NSAIDs. In addition, the dose-response relation of aspirin in reducing the risk of colorectal cancer has not been described. We carried out a population-based cohort study with secondary case-control analysis to determine the association between the risk of colorectal cancer and use of aspirin and individual NSAIDs, including the role of dose and duration. The General Practice Research Database in the U.K. was the source population. We traced 943,903 persons 40-79 years of age and free of cancer and colorectal adenoma between January 1994 and September 1997. A total of 2,002 incident cases of colorectal cancer were ascertained. The incidence rate of colorectal cancer per 10,000 person-years was 7.3. The risk of colorectal cancer was reduced in users of nonaspirin NSAIDs and became evident after 6 months of continuous treatment. The adjusted relative risk was 0.5 (95% confidence interval = 0.4-0.7). The reduction in risk disappeared completely 1 year after stopping NSAID treatment. The risk of developing colorectal cancer was reduced in long-term users of aspirin at doses of 300 mg daily (relative risk = 0.6; 95% confidence interval = 0.4-0.9). Daily doses of 75 and 150 mg aspirin were not associated with a reduced risk of colorectal cancer. Our data support the existence of an important protective effect of nonaspirin NSAID continuous intake against colorectal cancer and point to a similar reduction in risk for aspirin at doses of at least 300 mg daily. One-year treatment with NSAIDs would prevent one case of colorectal cancer in a population of 1,000 persons 70-79 years of age.

Integrity signals

Registry

Crossref · 10.1097/00001648-200101000-00015

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Aramandla, R., Giardiello, F. M., Ferrenbach, S., & DuBois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,512
Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E. L., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,095
Aspirin use and risk of fatal cancer.
Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., & Heath, C. W. (1993) · PubMed · Cited by 870
Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E. L., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 784
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study
Schreinemachers, D. M., & Everson, R. B. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00003 · Cited by 738
Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study
Kune, G. A., Kune, S., & Watson, L. F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym193 · Cited by 654
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H., Hacker, D. G., Hoover, R. N., & Fraumeni, J. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.307 · Cited by 580
Prophylactic aspirin and risk of peptic ulcer bleeding
Weil, J., Colin-Jones, D. G., Langman, M. J. S., Lawson, D. H., Logan, R., Murphy, M. S., Rawlins, M. D., Vessey, M. P., & Wainwright, P. (1995) · BMJ · doi:10.1136/bmj.310.6983.827 · Cited by 563

Show all 29 references

Research works printed but not linked: 4

Vainio, 1997, Cancer Epidemiol Biomarkers Prev, 6, 749
Kune, 1988, Cancer Res, 48, 4399
Reeves, 1996, Cancer Epidemiol Biomarkers Prev, 5, 955
Thun, 1993, Cancer Res, 53, 1322

Sorted by citations

Inflammation and cancer
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand‐Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,777
Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,430
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E. D., Keresztes, R. S., Petrelli, N. J., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,133
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT
Tlsty, T. D., & Coussens, L. M. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100224 · Cited by 1,006
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
Statins and the Risk of Colorectal Cancer
Poynter, J. N., Gruber, S. B., Higgins, P., Almog, R., Bonner, J. D., Rennert, H. S., Low, M., Greenson, J. K., & Rennert, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043792 · Cited by 814
Low-Dose Aspirin in the Primary Prevention of Cancer: The Women’s Health Study: A Randomized Controlled Trial
Cook, N. R., Lee, I.-M., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.47 · Cited by 796
Meta-analyses of colorectal cancer risk factors
Johnson, C. M., Wei, C., Ensor, J. E., Smolenski, D. J., Amos, C. I., Levin, B., & Berry, D. A. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0201-5 · Cited by 779
Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment
Basnet, P., & Škalko‐Basnet, N. (2011) · Molecules · doi:10.3390/molecules16064567 · Cited by 750
Primary Prevention of Colorectal Cancer
Chan, A. T., & Giovannucci, E. L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.057 · Cited by 758
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Cuzick, J. M., Otto, F., Baron, J. A., Brown, P. H., Burn, J., Greenwald, P., Jankowski, J. A., Vecchia, C. L., Meyskens, F. L., Senn, H. J., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70035-x · Cited by 713
Validity of the General Practice Research Database
Jick, S. S., Kaye, J. A., Vasilakis‐Scaramozza, C., Rodríguez, L. A. G., Ruigómez, A., Meier, C. R., Schlienger, R. G., Black, C., & Jick, H. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.5.686.32205 · Cited by 584
COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown, J. R., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.051 · Cited by 444
Cancer and the tumor microenvironment: a review of an essential relationship
Mbeunkui, F., & Johann, D. J. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0881-9 · Cited by 485
Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer
Chan, A. T. (2005) · JAMA · doi:10.1001/jama.294.8.914 · Cited by 479
Inflammatory Cells and Cancer
Coussens, L. M., & Werb, Z. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.f23 · Cited by 382
Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs
Patrono, C., Patrignani, P., & Rodríguez, L. A. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113418 · Cited by 362
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
Yang, Y., Hennessy, S., & Lewis, J. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.011 · Cited by 350
Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
Rostom, A., Dubé, C., Lewin, G., Tsertsvadze, A., Barrowman, N. J., Code, C., Sampson, M., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00010 · Cited by 343
The relationship between time since registration and measured incidence rates in the General Practice Research Database
Lewis, J. D., Bilker, W. B., Weinstein, R. B., & Strom, B. L. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1115 · Cited by 342
The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
Dubé, C., Rostom, A., Lewin, G., Tsertsvadze, A., Barrowman, N. J., Code, C., Sampson, M., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00009 · Cited by 335
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
Harris, R. E. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-8049-8 · Cited by 336
Understanding NSAIDs: From aspirin to COX-2
Green, G. A. (2001) · Clinical cornerstone · doi:10.1016/s1098-3597(01)90069-9 · Cited by 308
Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia
Sarkar, M., Hennessy, S., & Yang, Y. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-6-200809160-00005 · Cited by 301
Aspirin and cancer risk: a quantitative review to 2011
Bosetti, C., Rosato, V., Gallus, S., Cuzick, J. M., & Vecchia, C. L. (2012) · Annals of Oncology · doi:10.1093/annonc/mds113 · Cited by 297
The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression
Lin, E. Y., Gouon–Evans, V., Nguyen, A., & Pollard, J. W. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020399802795 · Cited by 291
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
Din, F. V. N., Τheodoratou, E., Farrington, S. M., Tenesa, A., Barnetson, R. A., Cetnarskyj, R., Stark, L. A., Porteous, M. E., Campbell, H., & Dunlop, M. G. (2010) · Gut · doi:10.1136/gut.2009.203000 · Cited by 282
Non-steroidal Anti-inflammatory Drug Use and the Risk of Gastric Cancer: A Systematic Review and Meta-analysis
Wang, W. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg106 · Cited by 268
Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota?
Boursi, B., Mamtani, R., Haynes, K., & Yang, Y. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.08.015 · Cited by 268
Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer
Jung, M. R., Park, Y. K., Jeong, O., Seon, J. W., Ryu, S. Y., Kim, D. Y., & Kim, Y. J. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21986 · Cited by 251
Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer
Shabani, F., Farasat, A., Mahdavi, M., & Gheibi, N. (2018) · Inflammation Research · doi:10.1007/s00011-018-1173-4 · Cited by 251
The Inflammatory Tumor Microenvironment and Its Impact on Cancer Development
de Visser, K. E., & Coussens, L. M. (2006) · KARGER eBooks · doi:10.1159/000092969 · Cited by 250
Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men
Chan, A. T., Giovannucci, E. L., Meyerhardt, J. A., Schernhammer, E. S., Wu, K., & Fuchs, C. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.035 · Cited by 241
Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer
Wang, D., Luo, H., Qiu, M., Wang, Z., Zhang, D.-S., Wang, F.-H., Li, Y.-H., & Xu, R. (2012) · Medical Oncology · doi:10.1007/s12032-012-0226-8 · Cited by 227
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study
Sørensen, H. T., Friis, S., Nørgård, B. M., Mellemkjær, L., Blot, W. J., McLaughlin, J. K., Ekbom, A., & Baron, J. A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600945 · Cited by 221
Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
Mohammed, S. I., Bennett, P. F., Craig, B. Α., Glickman, N. W., Mutsaers, A. J., Snyder, P. W., Widmer, W. R., DeGortari, A. E., Bonney, P. L., & Knapp, D. W. (2002) · PubMed · Cited by 197
Mixed-ligand copper( ii ) Schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity
Lian, W.-J., Wang, X., Xie, C., Tian, H., Song, X., Pan, H., Qiao, X., & Xu, J. (2016) · Dalton Transactions · doi:10.1039/c6dt00461j · Cited by 192
Cyclooxygenase-2 (COX-2) and the Inflammogenesis of Cancer
Harris, R. E. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_4 · Cited by 181
Copper(II) Complexes of Salicylic Acid Combining Superoxide Dismutase Mimetic Properties with DNA Binding and Cleaving Capabilities Display Promising Chemotherapeutic Potential with Fast Acting in Vitro Cytotoxicity against Cisplatin Sensitive and Resistant Cancer Cell Lines
O’Connor, M. J., Kellett, A., McCann, M., Rosair, G. M., McNamara, M. E., Howe, O. L., Creaven, B. S., McClean, S., Kia, A. F.-A., O′Shea, D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201041d · Cited by 168
Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies
Qiao, Y., Yang, T., Gan, Y., Li, W., Wang, C., Gong, Y., & Lu, Z. (2018) · BMC Cancer · doi:10.1186/s12885-018-4156-5 · Cited by 164
Epidemiology of Non-Steroidal Anti-Inflammatory Drugs and Cancer
Baron, J. A. (2003) · KARGER eBooks · doi:10.1159/000071364 · Cited by 161
Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects
Zhao, R., Coker, O. O., Wu, J., Zhou, Y., Zhao, L., Nakatsu, G., Bian, X., Wei, H., Chan, A. W. H., Sung, J. J. �., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.004 · Cited by 161
Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk
Friis, S., Riis, A. H., Erichsen, R., Baron, J. A., & Sørensen, H. T. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0039 · Cited by 159
Oleocanthal, a Phenolic Derived from Virgin Olive Oil: A Review of the Beneficial Effects on Inflammatory Disease
Parkinson, L., & Keast, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150712323 · Cited by 156
Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective Cohort
Ruder, E. H., Laiyemo, A. O., Graubard, B. I., Hollenbeck, A. R., Schatzkin, A. G., & Cross, A. J. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.38 · Cited by 152
A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin
Friis, S., Sørensen, H. T., McLaughlin, J. K., Johnsen, S. P., Blot, W. J., & Olsen, J. H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600760 · Cited by 151
Exposure-measurement error is frequently ignored when interpreting epidemiologic study results
Jurek, A. M., Maldonado, G., Greenland, S., & Church, T. R. (2006) · European Journal of Epidemiology · doi:10.1007/s10654-006-9083-0 · Cited by 151
Inflammation, carcinogenesis and cancer
Fitzpatrick, F. A. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00102-3 · Cited by 146
Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00008 · Cited by 140
Type 2 Diabetes Mellitus and the Risk of Colorectal Cancer
Yang, Y., Hennessy, S., & Lewis, J. D. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00152-7 · Cited by 139
Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams, J., Borgo, S., Hasan, I., Castillo, E., Traganos, F., & Rigas, B. (2001) · PubMed · Cited by 137
Exposure to statins and risk of common cancers: a series of nested case-control studies
Vinogradova, Y., Coupland, C. A. C., & Hippisley‐Cox, J. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-409 · Cited by 139
Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity
Spitz, G. A., Furtado, C. M., Sola‐Penna, M., & Zancan, P. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.020 · Cited by 135
Depression as a Risk Factor for Cancer: From Pathophysiological Advances to Treatment Implications
Currier, M. B., & Nemeroff, C. B. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-061212-171507 · Cited by 126
Chronic Proton Pump Inhibitor Therapy and the Risk of Colorectal Cancer
Yang, Y., Hennessy, S., Propert, K., Hwang, W., Sedarat, A., & Lewis, J. D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.022 · Cited by 125
Nonsteroidal Anti-inflammatory Drugs and the Esophageal Inflammation-Metaplasia-Adenocarcinoma Sequence
Anderson, L. A., Johnston, B. T., Watson, R. G. P., Murphy, S., Ferguson, H. R., Comber, H., McGuigan, J., Reynolds, J. V., & Murray, L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4253 · Cited by 123
Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer
Wang, D., Ren, C., Qiu, M., Luo, H., Wang, Z., Zhang, D.-S., Wang, F.-H., Li, Y.-H., & Xu, R. (2011) · Tumor Biology · doi:10.1007/s13277-011-0285-z · Cited by 122
COX-2, VEGF and tumour angiogenesis
Toomey, D. P., Murphy, J. F., & Conlon, K. C. (2009) · The Surgeon · doi:10.1016/s1479-666x(09)80042-5 · Cited by 122
Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin
Chun, K. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh076 · Cited by 121
Aspirin and cancer risk: an updated quantitative review to 2005
Bosetti, C., Gallus, S., & Vecchia, C. L. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0033-7 · Cited by 117
Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients
Chang, C., & Ulrich, C. M. (2003) · Diabetologia · doi:10.1007/s00125-003-1109-5 · Cited by 115
Olive Oil Effects on Colorectal Cancer
Borzì, A. M., Biondi, A., Basile, F., Luca, S., Vicari, E. S. D., & Vacante, M. (2018) · Nutrients · doi:10.3390/nu11010032 · Cited by 113
Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer
Paterson, J. R. (2001) · QJM · doi:10.1093/qjmed/94.8.445 · Cited by 112
Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer
Yamada, S., Fujii, T., Yabusaki, N., Murotani, K., Iwata, N., Kanda, M., Tanaka, C., Nakayama, G., Sugimoto, H., Koike, M., et al. (2016) · Medicine · doi:10.1097/md.0000000000003582 · Cited by 106
Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer
Yao, M., Lam, E., Kelly, C. R., Zhou, W., & Wolfe, M. M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601489 · Cited by 107
Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy
Iiizumi, M., Liu, W., Pai, S. K., Furuta, E., & Watabe, K. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.07.002 · Cited by 104
Using prescription claims data for drugs available over‐the‐counter (OTC)
Yood, M. U., Campbell, U. B., Rothman, K. J., Jick, S. S., Lang, J. M., Wells, K. E., Jick, H., & Johnson, C. C. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1454 · Cited by 102
Association Between Acetaminophen or Nonsteroidal Antiinflammatory Drugs and Risk of Developing Ovarian, Breast, or Colon Cancer
Meier, C. R., Schmitz, S., & Jick, H. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.5.303.33189 · Cited by 99
Inflammation in prostate cancer progression and therapeutic targeting.
Stark, T., Livas, L. I., & Kyprianou, N. (2015) · PubMed Central · doi:10.3978/j.issn.2223-4683.2015.04.12 · Cited by 100
Cholecystectomy and the Risk of Colorectal Cancer
Shao, T. H., & Yang, Y. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41610.x · Cited by 97
Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells
Nakayama, T., Mutsuga, N., Yao, L., & Tosato, G. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405226 · Cited by 93
No Increased Risk of Myocardial Infarction Among Patients With Ulcerative Colitis or Crohn's Disease
Osterman, M. T., Yang, Y., Brensinger, C. M., Forde, K. A., Lichtenstein, G. R., & Lewis, J. D. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.06.032 · Cited by 93
Risk of Colorectal Cancer in Patients Prescribed Statins, Nonsteroidal Anti-Inflammatory Drugs, and Cyclooxygenase-2 Inhibitors: Nested Case-Control Study
Vinogradova, Y., Hippisley‐Cox, J., Coupland, C. A. C., & Logan, R. F. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.023 · Cited by 91
Angiotensin-Converting Enzyme Inhibitor Therapy and Colorectal Cancer Risk
Makar, G. A., Holmes, J. H., & Yang, Y. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt374 · Cited by 90
Activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer
Hull, M. A., Gardner, S. H., & Hawcroft, G. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00014-8 · Cited by 87
Up-regulation of Endothelial Cyclooxygenase-2 and Prostanoid Synthesis by Platelets
Caughey, G. E., Cleland, L. G., Gamble, J. R., & James, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010606200 · Cited by 87
The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes
Smiechowski, B., Azoulay, L., Yin, H., Pollak, M., & Suissa, S. (2012) · Diabetes Care · doi:10.2337/dc12-0740 · Cited by 86
Potential use of routine databases in health technology assessment
Raftery, J. P., Roderick, P. J., & Stevens, A. J. (2005) · Health Technology Assessment · doi:10.3310/hta9200 · Cited by 85
Aspirin, NSAIDs, and Colorectal Cancer: Possible Involvement in an Insulin-Related Pathway
Slattery, M. L., Samowitz, W. S., Hoffman, M. D., Ne, K., Levin, T. R., & Neuhausen, S. L. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.538.13.4 · Cited by 85
Influence of the Mediterranean Diet on Healthy Aging
Andreo-López, M. C., Contreras-Bolívar, V., Muñoz‐Torres, M., García-Fontana, B., & García‐Fontana, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054491 · Cited by 94
A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity
Whitt, J. D., Nan, L., Tinsley, H. N., Chen, X., Zhang, W., Li, Y., Gary, B. D., Keeton, A. B., Xi, Y., Abadi, A., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0559 · Cited by 83
The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase‐2 negative colon cancer cells
Yu, H. ‐., Huang, J., Yang, Y. ‐., Huang, H., Luo, H., Yu, J., Meier, J. J., Schrader, H., Bastian, A., Schmidt, W. E., et al. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01080.x · Cited by 82
Association of Aspirin and Nonaspirin Nonsteroidal Anti-inflammatory Drugs With Cancer Incidence and Mortality
Bardia, A., Ebbert, J. O., Vierkant, R. A., Limburg, P. J., Anderson, K., Wang, A. H., Olson, J. E., Vachon, C., & Cerhan, J. R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk200 · Cited by 84
A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells
Deb, J., Majumder, J., Bhattacharyya, S., & Jana, S. S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-567 · Cited by 82
Individual and joint use of statins and low‐dose aspirin and risk of colorectal cancer: A population‐based case–control study
Hoffmeister, M., Chang-Claude, J. C., & Brenner, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22796 · Cited by 80
Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies
Goswami, B., Rajappa, M., SHARMA, M., & Sharma, A. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01089.x · Cited by 84
Prognostic Impact of Cyclooxygenase-2 in Breast Cancer
Denkert, C., Winzer, K., & Hauptmann, S. (2004) · Clinical Breast Cancer · doi:10.3816/cbc.2004.n.006 · Cited by 78
Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study
Mamtani, R., Lewis, J. D., Scott, F. I., Ahmad, T., Goldberg, D. S., Datta, J., Yang, Y., & Boursi, B. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002007 · Cited by 81
Inflammation, DAMPs, Tumor Development, and Progression: A Vicious Circle Orchestrated by Redox Signaling
Castellani, P., Balza, E., & Rubartelli, A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5164 · Cited by 86
Role of TLR2‐dependent inflammation in metastatic progression
Kim, S.-H., & Karin, M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05882.x · Cited by 78
Aspirin, Nonsteroidal Anti-inflammatory Drugs, Acetaminophen, and Pancreatic Cancer Risk: a Clinic-Based Case–Control Study
Tan, X., Lombardo, K. M. R., Bamlet, W. R., Oberg, A. L., Robinson, D. P., Anderson, K. E., & Petersen, G. M. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0146 · Cited by 77
Lung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromium
Beaver, L. M., Stemmy, E. J., Constant, S. L., Schwartz, A. M., Little, L. G., Gigley, J. P., Chun, G., Sugden, K. D., Ceryak, S. M., & Patierno, S. R. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.11.018 · Cited by 76
The Role of Cytokine Gene Polymorphisms in Colorectal Cancer and Their Interaction with Aspirin Use in the Northeast of Scotland
Macarthur, M., Sharp, L., Hold, G. L., Little, J., & El-Omar, E. M. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0878 · Cited by 78
Pharmacology and cellular/molecular mechanisms of action of aspirin and Non-aspirin NSAIDs in colorectal cancer
Schrör, K. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.10.016 · Cited by 76
Cyclooxygenase-2 in Cancer and Angiogenesis
Sahin, M. A., Şahın, E., & Gümüşlü, S. (2008) · Angiology · doi:10.1177/0003319708318378 · Cited by 76
Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS
Yang, J., Guo, X., Wang, M., Ma, X., Ye, X., & Lin, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-17130-6 · Cited by 79
Aspirin and the Risk of Hodgkin's Lymphoma in a Population-Based Case-Control Study
Chang, E. T., Zheng, T., Weir, E. G., Borowitz, M. J., Mann, R. B., Spiegelman, D. L., & Mueller, N. E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh038 · Cited by 76
Use of nonsteroidal anti‐inflammatory drugs and the risk of first‐time acute myocardial infarction
Schlienger, R. G., Jick, H., & Meier, C. R. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01637.x · Cited by 75

Authors: García Rodríguez, L. A., & Huerta-Alvarez, C.
Venue: Epidemiology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2001-01
Volume: 12
Issue: 1
Pages: 88-93
ISSN: 1044-3983 (ISSN-L)
DOI: 10.1097/00001648-200101000-00015
OpenAlex: W1971370481
Cited by: 359
References: 29
Citations by year: 2026: 1 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 11 · 2019: 6 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 15 · 2014: 11 · 2013: 14 · 2012: 19
FWCI: 16.04
Type: journal article
Language: en
Open access: closed
Locations: Epidemiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords: colorectal cancer, aspirin, nonsteroidal anti-inflammatory drugs, chemoprevention, dose-response relationship, long-term drug use, cancer incidence, colorectal adenoma
MeSH terms: Adenoma, Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Female, United Kingdom, Humans, Male, Middle Aged, Risk Factors, Colorectal Neoplasms, Cohort Studies, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks